burger
menu arrow
Features

Every tool you need for AI sales outreach

Independent AI sales assistant

An extra pair of hands for your sales growth

Prospecting with AI

Find leads with an appetite for your offer

Our best AI emails

Clients' favorite emails generated by AiSDR

End-to-end AI Sales Outreach

All your bases covered within one solution

AI for HubSpot sales

Make the best of your CRM data

Is AiSDR a fit for me?

See if your business is AI-ready

AiSDR Website Illustrations | Starts and lightning icon 1
Speak with our AI

Let AiSDR try and convince you to book a meeting with us

Human or AI? See if you can spot emails that were AI-generated Play the game
menu arrow
menu arrow

AI Prospecting for ShieldCo

ShieldCo is a leading provider of innovative defense and aerospace technologies, delivering cutting-edge solutions for national security and commercial aerospace industries.
laptop

Company data:

Company size:

14 employees

Industry

Defense and Aerospace

Headquarters:

123 Defense Blvd, Arlington, VA 22201, USA

Investment round:

Publicly Traded (NASDAQ: SHLD)

ARR:

$15 billion

Key stakeholders

These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates

Vincent Nichols
General Manager

Latest news about ShieldCo

Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates

The provided sources do not mention "ShieldCo" but instead refer to "Shield Therapeutics plc." Here is a summary of the latest significant news for Shield Therapeutics plc: Shield Therapeutics remains on track to be cash flow positive by the end of 2025, with Q1 2025 net revenues of $6.4 million from Accrufer® prescriptions, despite early challenges[2][4].

There is no available information on "ShieldCo" from the provided sources, as they all refer to "Shield Therapeutics plc." If you need information on Shield Therapeutics plc, here is a summary: Shield Therapeutics remains on track to be cash flow positive by the end of 2025, with Q1 2025 net revenues of $6.4 million from Accrufer® prescriptions, despite early challenges[2].

There is no available information on "ShieldCo" from the provided sources, as they all refer to "Shield Therapeutics plc."

Open job positions at ShieldCo

This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

Branch Sales Professional

Field Manager - Pest Control

AI sales outreach emails you can send to ShieldCo
See samples of how AiSDR handles your outbound emails with the prospecting data available
See how AiSDR will sell to you.
Share your info and get the first-hand experience
Start scaling your sales outreach today!